Voyager Biomedical is creating a better solution for vascular access in dialysis patients. They were referred to Amerra from another animation client and expressed the need to demonstrate their technology quickly and effectively to investor groups and business accelerator events. Amerra was tasked with developing a 2 minute animation to be used within Voyager’s technology pitch at the Texas A&M New Ventures
Voyager’s Chief Technology Officer, April Lovelady, PhD, was in the process of getting presentation guidance from a pitch-coach.
“I gave our presentation before we had the animation developed, and then once it was finished, our pitch-coach was confident that it would help us place or win our next pitch competition!”
Although they did not win this initial competition, the animation helped their message to be clear and concise, and the pitch subsequently earned Voyager a third place finish along with $25,000 award.
“We went from not placing the previous year to now winning 3rd place which was a huge boost to our momentum in both company awareness and funding.”
Voyager’s product, the ARK, a “One Stick, No Miss” solution to better vascular access will be used in dialysis which requires access to veins hundreds of times per year. The ARK has been designed to assist with locating veins, while preventing excess needle punctures and ensuring that needle is on target every time.
The team quickly began using the animation to reach investors beyond the successful pitch competition.
“We had a hard time getting our point across by having people visualize the technology and how it works, so understanding that an animation can tackle our problem led us to immediately realize it was the right investment.”
Voyager continues to utilize the animation to their advantage as it was part of the presentation for their admittance into the latest TMCx class. The Texas Medical Center Accelerator is a fast-paced accelerator program to help startups validate and refine their technologies, while still being able to engage potential investors.
“We learned that many investors have concerns with the time it can take to get a medical device product to market, but the animation is now closing those communication gaps”.